Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Capital City Bank Group (CCBG) - free report >>
Immunocore Holdings PLC Sponsored ADR (IMCR) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Capital City Bank Group (CCBG) - free report >>
Immunocore Holdings PLC Sponsored ADR (IMCR) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for July 12th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 12th:
Capital City Bank Group, Inc. (CCBG - Free Report) : This financial holding company for Capital City Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
Capital City Bank Group Price and Consensus
Capital City Bank Group price-consensus-chart | Capital City Bank Group Quote
Capital City’ shares gained 11.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of B.
Capital City Bank Group Price
Capital City Bank Group price | Capital City Bank Group Quote
Immunocore Holdings plc (IMCR - Free Report) : This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.4% over the last 60 days.
Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore Holdings PLC Sponsored ADR price-consensus-chart | Immunocore Holdings PLC Sponsored ADR Quote
Immunocore’s shares gained 12.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Immunocore Holdings PLC Sponsored ADR Price
Immunocore Holdings PLC Sponsored ADR price | Immunocore Holdings PLC Sponsored ADR Quote
F-star Therapeutics, Inc. : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.
Fstar Therapeutics, Inc. Price and Consensus
Fstar Therapeutics, Inc. price-consensus-chart | Fstar Therapeutics, Inc. Quote
F-star’s shares gained 86.8% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Fstar Therapeutics, Inc. Price
Fstar Therapeutics, Inc. price | Fstar Therapeutics, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.